from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2707/-

LFCtreatmentdescriptionclass of inhibitor

2.613

Amikacinug/mL Amikacintranslation

2.091

Cap5-10ug/mL Capreomycintranslation

2.974

Rox10-50 ug/mL Roxithromycintranslation

1.670

SM2-5 ug/mL Streptomycintranslation

2.427

Tet5-10 ug/mL Tetracyclinetranslation

-0.774

Rif0.2-5ug/mL Rifampicintranscription

-0.255

Rifp0.1-0.5ug/mL Rifapentinetranscription

-1.567

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.481

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.317

CPZ10-50 ug/mL Chlorpromazinerespiration

0.297

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.336

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

2.258

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.053

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.735

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.526

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.511

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.255

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.039

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

1.484

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

2.016

KCN5-20 ug/mL Potassium cyaniderespiration

0.137

NaN30.2-2 mM Sodium aziderespiration

1.043

Nigericin50 uM Nigericinrespiration

0.451

TRC10-150 ug/mL Triclosanrespiration

0.643

TRZ10-25 ug/mL Thioridazinerespiration

0.606

Valinomycin0.5-10 uM Valinomycinrespiration

-0.128

ZnSO42 mM ZnSO4respiration

1.946

menadione6-10 ug/mL Menadionerespiration

-0.023

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.370

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.127

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.255

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.925

NRP_1Non-replicating persistence stage 1dosRassociated

0.076

Amp0.2mg/mL AmpicillincellWall

-0.327

Cephalexin20-100 ug/mL CephalexincellWall

0.111

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.372

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.336

EMB10-20 ug/mL EthambutolcellWall

0.046

Eta12-40 ug/mL EthionamidecellWall

-0.060

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.255

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.893

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-1.033

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.820

BZA0.12 mg/mL BenzamidearomaticAmides

-0.683

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.066

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.374

H2O24 mM hydrogen peroxideDNAdamaging

-1.022

Levo10 ug/mL LevofloxacinDNAdamaging

-0.716

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.155

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.145

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.730

UVUV-irradiationDNAdamaging

2.964

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.697

Antimycin12.5-50 ug/mL Antimycin A?

-0.239

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.470

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.350

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.093

PA8240.2-2 ug/mL PA-824?

0.597

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.390

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.506

Verapamil50 uM Verapamil?

-0.387

mercaptoethanol2 mM 2-Mercaptoethanol?

0.060

methoxatin10-20 ug/mL Methoxatin?